Margarita Lopatin

Margarita Lopatin

UNVERIFIED PROFILE

Are you Margarita Lopatin?   Register this Author

Register author
Margarita Lopatin

Margarita Lopatin

Publications by authors named "Margarita Lopatin"

Are you Margarita Lopatin?   Register this Author

24Publications

513Reads

42Profile Views

12-Gene Recurrence Score Assay Stratifies the Recurrence Risk in Stage II/III Colon Cancer With Surgery Alone: The SUNRISE Study.

J Clin Oncol 2016 08 20;34(24):2906-13. Epub 2016 Jun 20.

Takeharu Yamanaka, National Cancer Center; Atsushi Ochiai, Atsushi Ohtsu, and Takayuki Yoshino, National Cancer Center Hospital East Chiba, Japan; Takeharu Yamanaka, Yokohama City University, Yokohama; Eiji Oki, Kyushu University; Tetsuya Kusumoto, National Kyushu Medical Center, Fukuoka; Kentaro Yamazaki, Shizuoka Cancer Center, Shizuoka; Kensei Yamaguchi and Kiwamu Akagi, Saitama Cancer Center, Saitama; Kensei Yamaguchi, Cancer Institute Hospital of Japanese Foundation for Cancer Research; Hiroyuki Uetake, Tokyo Medical and Dental University; Yasuo Ohashi, Chuo University, Tokyo; Kei Muro, Aichi Cancer Center Hospital, Nagoya; Takeo Sato, Kitasato University School of Medicine, Kanagawa; Tomohiro Nishina, National Hospital Organization Shikoku Cancer Center, Matsuyama; Masataka Ikeda, Osaka National Hospital; Akiyoshi Kanazawa, Kitano Hospital, Osaka; Takeshi Kato, Kansai Rosai Hospital, Amagasaki, Japan; Calvin Chao, Margarita Lopatin, Jayadevi Krishnakumar, and Helen Bailey, Genomic Health, Redwood City, CA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.0414DOI Listing
August 2016

Validation of the 12-gene colon cancer recurrence score as a predictor of recurrence risk in stage II and III rectal cancer patients.

J Natl Cancer Inst 2014 Nov 26;106(11). Epub 2014 Sep 26.

Department of Surgery (MSR, PJKK, GJL, CJHvdV) and Department of Medical Statistics (HP), Leiden University Medical Center, Leiden, the Netherlands; Genomic Health Inc., Redwood City, CA (MLe, MLo, HT, KCL, SS).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju269DOI Listing
November 2014

Prospective multicenter study of the impact of oncotype DX colon cancer assay results on treatment recommendations in stage II colon cancer patients.

Oncologist 2014 May 7;19(5):492-7. Epub 2014 Apr 7.

Mayo Clinic, Rochester, Minnesota, USA, Medical Oncology and Hematology Associates, Des Moines, Iowa, USA; Genomic Health, Inc., Redwood City, California, USA; Alegent Bergan Mercy Cancer Center, Omaha, Nebraska, USA; Cancer Center of Kansas, Wichita, Kansas, USA; Toledo Clinic, Toledo, Ohio, USA; Columbus Oncology Associates, Columbus, Ohio, USA; Mayo Clinic, Jacksonville, Florida, USA; Sanford Hospital, Sioux Falls, South Dakota, USA.

View Article

Download full-text PDF

Source
http://theoncologist.alphamedpress.org/cgi/doi/10.1634/theon
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2013-0401DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012966PMC
May 2014

Validation of the 12-gene colon cancer recurrence score in NSABP C-07 as a predictor of recurrence in patients with stage II and III colon cancer treated with fluorouracil and leucovorin (FU/LV) and FU/LV plus oxaliplatin.

J Clin Oncol 2013 Dec 12;31(36):4512-9. Epub 2013 Nov 12.

Greg Yothers, Michael J. O'Connell, Soonmyung Paik, Saima Sharif, and Norman Wolmark, National Surgical Adjuvant Breast and Bowel Project (NSABP) Operations and Biostatistical Centers; Greg Yothers, University of Pittsburgh Graduate School of Public Health; Saima Sharif and Norman Wolmark, Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA; Mark Lee, Margarita Lopatin, Kim M. Clark-Langone, and Steven Shak, Genomic Health, Redwood City, CA.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2013/11/04/JCO.2012.47
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2012.47.3116
Publisher Site
http://dx.doi.org/10.1200/JCO.2012.47.3116DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871512PMC
December 2013

Early vasoactive drugs improve heart failure outcomes.

Congest Heart Fail 2009 Nov-Dec;15(6):256-64

Department of Emergency Medicine, The Cleveland Clinic, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1751-7133.2009.00112.x
Publisher Site
http://dx.doi.org/10.1111/j.1751-7133.2009.00112.xDOI Listing
March 2010

Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry.

Cardiology 2009 17;113(1):12-9. Epub 2008 Oct 17.

Department of Emergency Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000164149DOI Listing
July 2009

Noninvasive ventilation outcomes in 2,430 acute decompensated heart failure patients: an ADHERE Registry Analysis.

Acad Emerg Med 2008 Apr;15(4):355-62

Department of Emergency Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1553-2712.2008.00059.xDOI Listing
April 2008

Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE.

Am J Cardiol 2008 Jan 3;101(2):231-7. Epub 2007 Dec 3.

Ahmanson-UCLA Cardiomyopathy Center, University of California, Los Angeles Medical Center, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2007.07.066DOI Listing
January 2008

Characteristics of patients hospitalized with acute decompensated heart failure who are referred for hospice care.

Arch Intern Med 2007 Oct;167(18):1990-7

Division of Cardiology, Saint Louis University Hospital, 3635 Vista Avenue, St Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archinte.167.18.1990DOI Listing
October 2007

Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.

J Am Coll Cardiol 2007 May 30;49(19):1943-50. Epub 2007 Apr 30.

Ahmanson-UCLA Cardiomyopathy Center, University of California, Los Angeles Medical Center, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2007.02.037DOI Listing
May 2007

An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry.

Am Heart J 2007 Jan;153(1):74-81

Ahmanson/University of California-Los Angeles Cardiomyopathy Center, University of California-Los Angeles Medical Center, Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2006.09.007DOI Listing
January 2007

Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database.

J Am Coll Cardiol 2006 Jan 15;47(1):76-84. Epub 2005 Dec 15.

Division of Cardiology, Department of Medicine, University of Texas Southwest Medical Center, Dallas, Texas 75390-9047, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2005.09.022DOI Listing
January 2006

Home use of the GlucoWatch G2 biographer in children with diabetes.

Pediatrics 2005 Mar;115(3):662-6

Pediatric Diabetes Center, Loma Linda University, 11175 Campus St, CP A1120R, Loma Linda, CA 92354, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1542/peds.2004-0820DOI Listing
March 2005

Use of the GlucoWatch biographer in children with type 1 diabetes.

Pediatrics 2003 Apr;111(4 Pt 1):790-4

Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1542/peds.111.4.790DOI Listing
April 2003